• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Myriad Genetics, Inc. - Common Stock (NQ:MYGN)

5.850 UNCHANGED
Delayed Quote Updated: 4:00 PM EST, Nov 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,374
Open 5.850
Bid (Size) 5.300 (100)
Ask (Size) 5.850 (100)
Prev. Close 5.850
Today's Range 5.850 - 5.850
52wk Range 2.740 - 8.380
Shares Outstanding 94,400,000
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Earnings to watch: Myriad Genetics (MYGN) reports Q3 results tomorrow
November 02, 2026
Genetic testing company Myriad Genetics (NASDAQ:MYGN) will be announcing earnings results this Wednesday afternoon. Here’s what to expect. Myriad Genetics mi... 
Via StockStory
News headline image
Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences
November 02, 2026
From Myriad Genetics, Inc.
Via GlobeNewswire

Performance

52-Week Range 30.2% below 52-week high
5.850
2.7452W Low 8.3852W High
1 Week 13.6% below 1-week high
5.821W Low 6.771W High

Myriad Genetics, Inc. - Common Stock (MYGN) traded between $2.74 and $8.38 over the past 52 weeks and last traded at $5.85, 30.2% below its 52-week high. Over the past week it ranged between $5.82 and $6.77.

Past 12 Months
-7.0%
+27.7%
+93.7%
+18.4%
-4.7%
-28.3%
1W -$0.44
1M +$1.27
3M +$2.83
6M +$0.91
YTD -$0.29
1Y -$2.31

MYGN was -28.3% over the past year, +18.4% over six months, -4.7% year to date, -7.0% in the last week.

12 Months vs Market
MYGN
-28.3%
DIA
+9.7%
SPY
+10.1%
QQQ
+7.8%
IWM
+13.7%

Over the past 12 months MYGN returned -28.3% versus DIA (Dow) +9.7%, SPY (S&P 500) +10.1%, QQQ (Nasdaq 100) +7.8% and IWM (Russell 2000) +13.7%.

Volume & Liquidity 0.00× 3-mo avg
Today 1,374 3-mo avg 2.4M
1W
1.8M
1M
3.1M
3M
2.4M
6M
2.1M
YTD
1.9M
1Y
1.8M

MYGN most recently traded 1,374 shares against a 3-month average daily volume of 2.4M.

More News

Read More
News headline image
2 Russell 2000 stocks on our watchlist and 1 we ignore
October 29, 2026
Via StockStory
News headline image
Myriad Genetics Releases New MONSTAR-SCREEN-3 Data Demonstrating the Potential of Ultra-Sensitive MRD Detection in Colorectal and Pancreatic Cancers
October 22, 2026
From Myriad Genetics, Inc.
Via GlobeNewswire
News headline image
Stocks making big moves yesterday: Washington Trust Bancorp, Doximity, Myriad Genetics, Arhaus, and Gartner
October 21, 2026
Via StockStory
Top US Stock Movers: Today's Session Gainers and Losers ↗
October 20, 2026
Via Chartmill
Top Movers: Gainers Rise 55.88%, Losers Fall 53.13% in Today's Session ↗
October 20, 2026
Via Chartmill
Gap Stocks: Gap-Up and Gap-Down Movers in Today's Session ↗
October 20, 2026
Via Chartmill
News headline image
Myriad Genetics (MYGN) Stock Trades Up, Here Is Why
October 20, 2026
Via StockStory
Topics Artificial Intelligence
News headline image
Myriad Genetics and Labcorp Announce Definitive Agreement for Myriad to Sell Prenatal Health Testing Business to Labcorp
October 20, 2026
From Myriad Genetics, Inc.
Via GlobeNewswire
News headline image
2 Small-Cap Stocks to Consider Right Now and 1 We Turn Down
October 19, 2026
Via StockStory
News headline image
Azenta, Myriad Genetics, Moderna, Repligen, and PacBio Shares Plummet, What You Need To Know
October 16, 2026
Via StockStory
Topics Bonds Economy
News headline image
Myriad Genetics to Release Third Quarter 2026 Financial Results on November 4, 2026
October 15, 2026
From Myriad Genetics, Inc.
Via GlobeNewswire
News headline image
Q2 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks
October 14, 2026
Via StockStory
Topics Artificial Intelligence
News headline image
Myriad Genetics and SOPHiA GENETICS Announce New Collaboration to Advance Prostate Genomic Instability Score Technology
October 08, 2026
From Myriad Genetics, Inc.
Via GlobeNewswire
News headline image
Therapeutics Stocks Q2 Highlights: Gilead Sciences (NASDAQ:GILD)
October 07, 2026
Via StockStory
Topics Artificial Intelligence
News headline image
Why Is Myriad Genetics (MYGN) Stock Soaring Today
October 02, 2026
Via StockStory
News headline image
1 Volatile Stock on Our Buy List and 2 We Question
October 02, 2026
Via StockStory
News headline image
3 Reasons MYGN is Risky and 1 Stock to Buy Instead
September 24, 2026
Via StockStory
Topics Bankruptcy
News headline image
Reflecting On Therapeutics Stocks’ Q2 Earnings: AbbVie (NYSE:ABBV)
September 21, 2026
Via StockStory
Topics Artificial Intelligence
News headline image
1 Unpopular Stock That Deserves Some Love and 2 We Turn Down
September 17, 2026
Via StockStory
News headline image
Myriad Genetics Appoints Vishal Sikri Executive Vice President - Commercial
September 16, 2026
From Myriad Genetics, Inc.
Via GlobeNewswire
News headline image
2 Unprofitable Stocks to Research Further and 1 We Find Risky
September 15, 2026
Via StockStory
News headline image
Q2 Rundown: Vertex Pharmaceuticals (NASDAQ:VRTX) Vs Other Therapeutics Stocks
September 09, 2026
Via StockStory
Topics Artificial Intelligence
News headline image
Therapeutics Stocks Q2 Recap: Benchmarking Myriad Genetics (NASDAQ:MYGN)
September 07, 2026
Via StockStory
Topics Artificial Intelligence

Frequently Asked Questions

Is Myriad Genetics, Inc. - Common Stock publicly traded?
Yes, Myriad Genetics, Inc. - Common Stock is publicly traded.
What exchange does Myriad Genetics, Inc. - Common Stock trade on?
Myriad Genetics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Myriad Genetics, Inc. - Common Stock?
The ticker symbol for Myriad Genetics, Inc. - Common Stock is MYGN on the Nasdaq Stock Market
What is the current price of Myriad Genetics, Inc. - Common Stock?
The current price of Myriad Genetics, Inc. - Common Stock is 5.850
When was Myriad Genetics, Inc. - Common Stock last traded?
The last trade of Myriad Genetics, Inc. - Common Stock was at 11/02/26 04:00 PM ET
What is the market capitalization of Myriad Genetics, Inc. - Common Stock?
The market capitalization of Myriad Genetics, Inc. - Common Stock is 552.24M
How many shares of Myriad Genetics, Inc. - Common Stock are outstanding?
Myriad Genetics, Inc. - Common Stock has 552M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap